Xencor Inc
Engineering antibody & cytokine therapeutics for cancer and autoimmune diseases via its XmAb platform.
XNCR | US
Overview
Corporate Details
- ISIN(s):
- US98401F1057
- LEI:
- Country:
- United States of America
- Address:
- 465 N. HALSTEAD ST., 91107 PASADENA
- Website:
- https://xencor.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Xencor Inc. is a clinical-stage biopharmaceutical company engineering antibody and cytokine therapeutics for the treatment of cancer and autoimmune diseases. The company's drug development is powered by its proprietary XmAb® protein engineering platform, which creates novel drug candidates by modifying the Fc domain of antibodies. This technology enables the creation of bispecific antibodies that can target multiple disease mechanisms simultaneously, while also improving therapeutic properties like half-life, stability, and ease of manufacturing. Xencor maintains a broad pipeline with over 20 programs in clinical development and has several XmAb-engineered medicines marketed by strategic partners, highlighting its "plug-and-play" technology model.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Xencor Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xencor Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xencor Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
